About: Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2006 (uk) im August 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 2006 (ast) scientific article published on 01 August 2006 (en)
publication date	wds:Q80098829-6F89BD82-EF62-49AC-8055-58DB4EA67B37
publication date	2006-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q80098829-EAD5C903-1358-4492-AC3F-C8728B5C71C3
language of work or name	English
cites work	wds:Q80098829-0BABC6FF-0CBC-4E7A-A52C-C973B1564733 wds:Q80098829-112FA2A3-3B1A-44BB-A01E-45793A1084B8 wds:Q80098829-18B8453F-8566-45C1-88BD-3D0F53667EAE wds:Q80098829-1B24BDE6-D2EC-4CD5-BA5F-AF9104B3DDE9 wds:Q80098829-35CF0C1E-2ECD-4544-8D8B-AEE13E69011A wds:Q80098829-4A6D6D8A-7C16-41E5-B53A-D410ADBED997 wds:Q80098829-50C5DB8A-3DE0-4462-A7F8-EB0B245FF5A4 wds:Q80098829-50CF5340-D1D3-4741-A178-9EB1D1526B36 wds:Q80098829-5BEBCD92-7BC3-4B19-A5AD-93A8C20ABCC7 wds:Q80098829-5F7EEBDB-4E41-43D0-AA4B-23A377CB916E wds:Q80098829-6CD9926E-A253-4A7F-A5F9-B528DA28A7B5 wds:Q80098829-6FBCA935-8CC9-4499-9388-775350C3A8D5 wds:Q80098829-7E172278-1019-4690-B601-B3ECFD1736C8 wds:Q80098829-7EEB9E37-EDA0-4C23-8945-1B1D08CE3CB1 wds:Q80098829-874D4655-B5A8-4AEE-9DA1-8EB8E5763B0C wds:Q80098829-88DD65B8-EEA2-4C46-AFE0-CF4D4CA5BFC5 wds:Q80098829-9ADD8893-0731-4D49-9A87-F75AED4EDFFB wds:Q80098829-9B03136C-BB16-469A-83F8-D98C71B69C1B wds:Q80098829-AA169870-63D4-4A8D-B335-351D31EEA899 wds:Q80098829-AC5FCC92-F100-43D7-98FF-B3A4708C7D35 wds:Q80098829-B089ADB8-F7A4-4039-A37A-2FFE4408C4EE wds:Q80098829-BA13D63D-E944-4FA3-BC52-B1307634939B wds:Q80098829-DDDF8A05-7378-47FB-BD48-482FBDE22A9E wds:Q80098829-E34F072B-D5B8-42C4-A47F-1C66BF4C2CCC
cites work	The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up Comparison of microscopic vascularity in benign and malignant prostate tissue Effects of finasteride on vascular endothelial growth factor Transurethral prostate resection and bleeding: a randomized, placebo controlled trial of role of finasteride for decreasing operative blood loss Effects of finasteride and bicalutamide on prostatic blood flow in the rat Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Symptoms and signs of prostatism as risk factors for prostatectomy The finasteride prostate cancer prevention trial (PCPT)--what have we learned? Quality-of-life aspects in urology - benign prostatic hyperplasia Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia The treatment of gross hematuria secondary to prostatic bleeding with finasteride Resistance to caspase-dependent, hypoxia-induced apoptosis is not hypoxia-inducible factor-1 alpha mediated in prostate carcinoma cells
author name string	wds:Q80098829-5DF075A7-A2AA-4681-B9A1-EBC53E6D0454 wds:Q80098829-67DB7D0C-BF48-4A19-B4FF-5C6A36381EB9 wds:Q80098829-818A882A-57B6-4D95-AC3E-D4D319EFB1DE wds:Q80098829-A2D0AF08-0446-4902-8E3C-8F5D6D7F382B wds:Q80098829-B026364C-2B36-4F8C-AF4A-3E7211CCADC7 wds:Q80098829-DB93AE3F-D8C2-4204-9091-31F4B48D9228 wds:Q80098829-DF59A6B6-7627-451D-A887-C730A52D086E
author name string	Efstratios Patsouris Andreas C Lazaris Athanasios G Papatsoris Michael Chrisofos Dimitrios Lappas Charalampos Deliveliotis Alexandros G Lekas
rdfs:label	Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia (en) Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia (nl)
skos:prefLabel	Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia (en) Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia (nl)
name	Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia (en) Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia (nl)
title	wds:Q80098829-47B48765-2ED2-488E-A594-8627DC4CA187
title	Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia (en)
page(s)	wds:Q80098829-F07F385F-277E-4FFE-B297-7DE7060F180F
page(s)	436-441
instance of	wds:Q80098829-508752FA-EF6A-4F31-A37D-855D06217DAF
instance of	scholarly article
main subject	wds:Q80098829-A0D09A24-CF87-4EB8-8941-F90FEA41B0B5
main subject	prostatic hypertrophy
PubMed ID	wds:Q80098829-EA78B372-FF2A-4692-9CA8-9214980F7B2E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16904480
PubMed ID	16904480
published in	wds:Q80098829-FE4C274F-CE7D-4336-B21A-DBE25C30E4A9
published in	Urology
issue	wds:Q80098829-28A8BCA9-8217-40C8-8349-721B0F9665FA
volume	wds:Q80098829-709844A7-1501-4568-9E88-0CDB33613331
issue	2
volume	68
DOI	wds:Q80098829-EA4DE183-7CF5-4DDE-9FDC-75D1211E3DE8
DOI	http://dx.doi.org/10.1016/J.UROLOGY.2006.03.038
DOI	10.1016/J.UROLOGY.2006.03.038
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80098829
is cites work of	Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trials

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software